Staphylococci in colonization and disease: Prospective targets for drugs and vaccines

Current Opinion in Microbiology

Volumn 7, Issue 5, 2004, Pages 477-487

  Götz, Friedrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; ANTIBIOTIC AGENT; BINDING PROTEIN; CADAVERINE; CHIMERIC PROTEIN; DNA VACCINE; FIBRONECTIN BINDING PROTEIN; GALLIDERMIN; IMMUNOGLOBULIN; LANTIBIOTIC; LINEZOLID; MANNOPEPTIMYCIN DERIVATIVE; MEMBRANE LIPID; MERSACIDIN; METHIONINE TRANSFER RNA; METICILLIN; MUTANT PROTEIN; NISIN; PEPTIDE DEFORMYLASE; PEPTIDOGLYCAN; PERTUSSIS VACCINE; PLASMID DNA; POLYSACCHARIDE; RAMOPLANIN; SORTASE; STAPHYLOCOCCUS TOXIN; TEICHOIC ACID; TOXIC SHOCK SYNDROME TOXIN 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ACTIVE IMMUNIZATION; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM MUTANT; BINDING AFFINITY; BIOFILM; BIOSYNTHESIS; CELL ADHESION; CELL STRUCTURE; CELL WALL; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME MECHANISM; ESCHERICHIA COLI; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNIZATION; LACTOCOCCUS LACTIS; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL ADHESION; NONHUMAN; NUCLEOTIDE SEQUENCE; PASSIVE IMMUNIZATION; PROTEIN BINDING; PROTEIN INTERACTION; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS CARNOSUS; STAPHYLOCOCCUS EPIDERMIDIS; VIRULENCE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; IMMUNIZATION, PASSIVE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS; VACCINATION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LACTOCOCCUS LACTIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS CARNOSUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS;

EID: 4644255644     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2004.08.014     Document Type: Review

References (75)

1. Götz F, Bannerman T, Schleifer KH: The Genera Staphylococcus and Macrococcus. In The Procaryotes, edn http://141.150.157.117:8080/prokWIP/ chaphtm/356/COMPLETE.htm. Edited by Dworkin M: Springer; 2004: http://141.150.157.117:8080/prokWIP/chaphtm/8356/COMPLETE.htm. vol Release 3.17.]
2. P. Hagan, S. Projan, and J. Rosamond Infectious diseases: back to the future? Trends Microbiol 10 2002 S1 S2
3. S.J. Projan, and P.J. Youngman Antimicrobials: new solutions badly needed Curr Opin Microbiol 5 2002 463 465
4. M. Matsuo, K. Kurokawa, S. Nishida, Y. Li, H. Takimura, C. Kaito, N. Fukuhara, H. Maki, K. Miura, and K. Murakami Isolation and mutation site determination of the temperature-sensitive murB mutants of Staphylococcus aureus FEMS Microbiol Lett 222 2003 107 113
5. A. Severin, K. Tabei, F. Tenover, M. Chung, N. Clarke, and A. Tomasz High level oxacillin and vancomycin resistance and altered cell wall composition in Staphylococcus aureus carrying the staphylococcal mecA and the enterococcal vanA gene complex J Biol Chem 279 2004 3398 3407
6. S. Rohrer, and B. Berger-Bächi FemABX peptidyl transferases: a link between branched-chain cell wall peptide formation and beta-lactam resistance in Gram-positive cocci Antimicrob Agents Chemother 47 2003 837 846 This article summarizes the results on the pentaglycine bridge formation in S. aureus. The genetic and biochemical evidence suggest that the sequential addition of these glycines is catalyzed by three homologous enzymes, FemX (FmhB), FemA and FemB. These enzymes represent very promising targets for antibiotic design.
7. T.E. Benson, D.B. Prince, V.T. Mutchler, K.A. Curry, A.M. Ho, R.W. Sarver, J.C. Hagadorn, G.H. Choi, and R.L. Garlick X-ray crystal structure of Staphylococcus aureus FemA Structure (Camb) 10 2002 1107 1115 FemA is involved in the pentaglycine bridge formation in Staphylococcus. Its structure elucidation is a basis for designing new inhibitors.
8. A. Peschel How do bacteria resist human antimicrobial peptides? Trends Microbiol 10 2002 179 186 This review gives an overview on mechanisms that S. aureus and other pathogens are using to resist cationic antimicrobial peptides an important human defense regime.
9. C. Weidenmaier, J.F. Kokai-Kun, S.A. Kristian, T. Chanturiya, H. Kalbacher, M. Gross, G. Nicholson, B. Neumeister, J.J. Mond, and A. Peschel Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections Nat Med 10 2004 243 245 This article provides for the first time clear evidences that the wall teichoic acid of S. aureus is a major colonization factor of the anterior nares in a cotton rat nare colonization model.
10. L.V. Collins, S.A. Kristian, C. Weidenmaier, M. Faigle, K.P. Van Kessel, J.A. Van Strijp, F. Götz, B. Neumeister, and A. Peschel Staphylococcus aureus strains lacking d-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice J Infect Dis 186 2002 214 219 The lack of d-alanine incorporation into teichoic acids in the staphylococcal cell envelope decreases defensin resistance and virulence. Thus the dlt operon represents an interesting target.
11. S.A. Kristian, X. Lauth, V. Nizet, F. Götz, B. Neumeister, A. Peschel, and R. Landmann Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model J Infect Dis 188 2003 414 423
12. F. Götz, and G. Jung Biosynthesis of the lantibiotics epidermin and gallidermin V. Braun F. Götz Microbial fundamentals of biotechnology 2001 WILEY-VCH Verlag GmbH 52 92
13. C. Weidenmaier, S.A. Kristian, and A. Peschel Bacterial resistance to antimicrobial host defenses - an emerging target for novel antiinfective strategies? Curr Drug Targets 4 2003 643 649
14. P. Staubitz, H. Neumann, T. Schneider, I. Wiedemann, and A. Peschel MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance FEMS Microbiol Lett 231 2004 67 71
15. S.A. Kristian, M. Dürr, J.A. Van Strijp, B. Neumeister, and A. Peschel MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing Infect Immun 71 2003 546 549
16. F. Götz Staphylococcus and biofilms Mol Microbiol 43 2002 1367 1378
17. P. Francois, P.H. Tu Quoc, C. Bisognano, W.L. Kelley, D.P. Lew, J. Schrenzel, S.E. Cramton, F. Götz, and P. Vaudaux Lack of biofilm contribution to bacterial colonisation in an experimental model of foreign body infection by Staphylococcus aureus and Staphylococcus epidermidis FEMS Immunol Med Microbiol 35 2003 135 140
18. S.A. Kristian, T. Golda, F. Ferracin, S.E. Cramton, B. Neumeister, A. Peschel, F. Götz, and R. Landmann The ability of biofilm formation does not influence virulence of Staphylococcus aureus and host response in a mouse tissue cage infection model Microb Pathog 36 2004 237 245
19. J.G. Joyce, C. Abeygunawardana, Q. Xu, J.C. Cook, R. Hepler, C.T. Przysiecki, K.M. Grimm, K. Roper, C.C. Ip, and L. Cope Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus Carbohydr Res 338 2003 903 922
20. M.C. McElroy, D.J. Cain, C. Tyrrell, T.J. Foster, and C. Haslett Increased virulence of a fibronectin-binding protein mutant of Staphylococcus aureus in a rat model of pneumonia Infect Immun 70 2002 3865 3873
21. U. Schwarz-Linek, J.M. Werner, A.R. Pickford, S. Gurusiddappa, J.H. Kim, E.S. Pilka, J.A. Briggs, T.S. Gough, M. Hook, and I.D. Campbell Pathogenic bacteria attach to human fibronectin through a tandem beta-zipper Nature 423 2003 177 181
22. E. Mongodin, O. Bajolet, J. Cutrona, N. Bonnet, F. Dupuit, E. Puchelle, and S. de Bentzmann Fibronectin-binding proteins of Staphylococcus aureus are involved in adherence to human airway epithelium Infect Immun 70 2002 620 630
23. B. Sinha, P. Francois, Y.A. Que, M. Hussain, C. Heilmann, P. Moreillon, D. Lew, K.H. Krause, G. Peters, and M. Herrmann Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells Infect Immun 68 2000 6871 6878
24. C. Heilmann, G. Thumm, G.S. Chhatwal, J. Hartleib, A. Uekotter, and G. Peters Identification and characterization of a novel autolysin (Aae) with adhesive properties from Staphylococcus epidermidis Microbiology 149 2003 2769 2778
25. S.R. Clarke, L.G. Harris, R.G. Richards, and S.J. Foster Analysis of Ebh, a 1.1-megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus Infect Immun 70 2002 6680 6687
26. M. Flock, K. Jacobsson, L. Frykberg, T.R. Hirst, A. Franklin, B. Guss, and J.I. Flock Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses Infect Immun 72 2004 3228 3236
27. O. Shannon, and J.I. Flock Extracellular fibrinogen binding protein, Efb, from Staphylococcus aureus binds to platelets and inhibits platelet aggregation Thromb Haemost 91 2004 779 789
28. E. Brouillette, P. Lacasse, L. Shkreta, J. Belanger, G. Grondin, M.S. Diarra, S. Fournier, and B.G. Talbot DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureus Vaccine 20 2002 2348 2357
29. C.C. Deivanayagam, E.R. Wann, W. Chen, M. Carson, K.R. Rajashankar, M. Hook, and S.V. Narayana A novel variant of the immunoglobulin fold in surface adhesins of Staphylococcus aureus: crystal structure of the fibrinogen-binding MSCRAMM, clumping factor A EMBO J 21 2002 6660 6672 For anti-adhesive drug design it is important to know that the fibrinogen and collagen-binding protein of S. aureus contain similarly folded domains as the immunoglobulin.
30. F.M. Roche, M. Meehan, and T.J. Foster The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells Microbiology 149 2003 2759 2767
31. A. Haggar, M. Hussain, H. Lonnies, M. Herrmann, A. Norrby-Teglund, and J.I. Flock Extracellular adherence protein from Staphylococcus aureus enhances internalization into eukaryotic cells Infect Immun 71 2003 2310 2317
32. M. Hussain, A. Haggar, C. Heilmann, G. Peters, J.I. Flock, and M. Herrmann Insertional inactivation of Eap in Staphylococcus aureus strain Newman confers reduced staphylococcal binding to fibroblasts Infect Immun 70 2000 2933 2940
33. C. Cucarella, M.A. Tormo, C. Ubeda, M.P. Trotonda, M. Monzon, C. Peris, B. Amorena, I. Lasa, and J.R. Penades Role of biofilm-associated protein bap in the pathogenesis of bovine Staphylococcus aureus Infect Immun 72 2004 2177 2185
34. J. Bjerketorp, M. Nilsson, A. Ljungh, J.I. Flock, K. Jacobsson, and L. Frykberg A novel von Willebrand factor binding protein expressed by Staphylococcus aureus Microbiology 148 2002 2037 2044
35. M.O. Elasri, J.R. Thomas, R.A. Skinner, J.S. Blevins, K.E. Beenken, C.L. Nelson, and M.S. Smelter Staphylococcus aureus collagen adhesin contributes to the pathogenesis of osteomyelitis Bone 30 2002 275 280
36. Y. Zong, T.W. Bice, H. Ton-That, O. Schneewind, and S.V. Narayana Crystal structures of Staphylococcus aureus sortase A and its substrate complex J Biol Chem 279 2004 31383 31389
37. F.M. Roche, R. Massey, S.J. Peacock, N.P. Day, L. Visai, P. Speziale, A. Lam, M. Pallen, and T.J. Foster Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences Microbiology 149 2003 643 654
38. Y. Zong, S.K. Mazmanian, O. Schneewind, and S.V. Narayana The structure of sortase B, a cysteine transpeptidase that tethers surface protein to the Staphylococcus aureus cell wall Structure (Camb) 12 2004 105 112
39. I.M. Jonsson, S.K. Mazmanian, O. Schneewind, M. Verdrengh, T. Bremell, and A. Tarkowski On the role of Staphylococcus aureus sortase and sortase-catalyzed surface protein anchoring in murine septic arthritis J Infect Dis 185 2002 1417 1424
40. B. Haslinger, K. Strangfeld, G. Peters, K. Schulze-Osthoff, and B. Sinha Staphylococcus aureus alpha-toxin induces apoptosis in peripheral blood mononuclear cells: role of endogenous tumour necrosis factor-alpha and the mitochondrial death pathway Cell Microbiol 5 2003 729 741
41. F. Essmann, H. Bantel, G. Totzke, I.H. Engels, B. Sinha, K. Schulze-Osthoff, and R.U. Janicke Staphylococcus aureus alpha-toxin-induced cell death: predominant necrosis despite apoptotic caspase activation Cell Death Differ 10 2003 1260 1272
42. Bernardo K, Pakulat N, Fleer S, Schnaith A, Utermohlen O, Krut O, Muller S, Kronke M: Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob Agents Chemother 2004, 48:546-444.
43. S. Galdiero, and E. Gouaux High resolution crystallographic studies of {alpha}-hemolysin-phospholipid complexes define heptamer-lipid head group interactions: Implication for understanding protein-lipid interactions Protein Sci 13 2004 1503 1511
44. P.W. Park, T.J. Foster, E. Nishi, S.J. Duncan, M. Klagsbrun, and Y. Chen Activation of syndecan-1 ectodomain shedding by Staphylococcus aureus alpha-toxin and beta-toxin J Biol Chem 279 2004 251 258
45. V. Boussaud, A. Parrot, C. Mayaud, M. Wislez, M. Antoine, C. Picard, F. Delisle, J. Etienne, and J. Cadranel Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus Intensive Care Med 29 2003 1840 1843
46. Y. Gillet, B. Issartel, P. Vanhems, J.C. Fournet, G. Lina, M. Bes, F. Vandenesch, Y. Piemont, N. Brousse, and D. Floret Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients Lancet 359 2002 753 759
47. N. Morinaga, Y. Kaihou, and M. Noda Purification, cloning and characterization of variant LukE-LukD with strong leukocidal activity of staphylococcal bi-component leukotoxin family Microbiol Immunol 47 2003 81 90
48. V. Gauduchon, G. Cozon, F. Vandenesch, A.L. Genestier, N. Eyssade, S. Peyrol, J. Etienne, and G. Lina Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro J Infect Dis 189 2004 346 353
49. J.K. McCormick, T.J. Tripp, A.S. Llera, E.J. Sundberg, M.M. Dinges, R.A. Mariuzza, and P.M. Schlievert Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes J Immunol 171 2003 1385 1392
50. D.L. Hu, K. Omoe, S. Sasaki, H. Sashinami, H. Sakuraba, Y. Yokomizo, K. Shinagawa, and A. Nakane Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection J Infect Dis 188 2003 743 752
51. Y. Le Loir, F. Baron, and M. Gautier Staphylococcus aureus and food poisoning Genet Mol Res 2 2003 63 76
52. C.C. Wang, W.T. Lo, C.F. Hsu, and M.L. Chu Enterotoxin B is the predominant toxin involved in staphylococcal scarlet Fever in Taiwan Clin Infect Dis 38 2004 1498 1502
53. M. Gupta-Malhotra, A. Viteri-Jackson, W. Thomas, and J.B. Zabriskie Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease Exp Mol Pathol 76 2004 117 121
54. E. Hong-Geller, M. Mollhoff, P.R. Shiflett, and G. Gupta Design of chimeric receptor mimics with different TcRVbeta isoforms. Type-specific inhibition of superantigen pathogenesis J Biol Chem 279 2004 5676 5684
55. Y. Hanakawa, N.M. Schechter, C. Lin, L. Garza, H. Li, T. Yamaguchi, Y. Fudaba, K. Nishifuji, M. Sugai, and M. Amagai Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome J Clin Invest 110 2002 53 60 Exfoliative toxins of S. aureus are responsible for the staphylococcal scalded skin syndrome, a blistering skin disorder. The verification as the glutamate-specific trypsin-like serine protease and the identification of its target desmoglein-51, a desmosomal glycoprotein, is a major brake through in finding new antitoxin strategies for the treatment and prevention of the staphylococcal scalded skin syndrome.
56. T. Yamaguchi, K. Nishifuji, M. Sasaki, Y. Fudaba, M. Aepfelbacher, T. Takata, M. Ohara, H. Komatsuzawa, M. Amagai, and M. Sugai Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B Infect Immun 70 2002 5835 5845
57. P. Ahrens, and L.O. Andresen Cloning and sequence analysis of genes encoding Staphylococcus hyicus exfoliative toxin types A, B, C, and D J Bacteriol 186 2004 1833 1837
58. S. Ladhani Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus FEMS Immunol Med Microbiol 39 2003 181 189
59. W. Brumfitt, M.R. Salton, and J.M. Hamilton-Miller Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci J Antimicrob Chemother 50 2002 731 734
60. I. Wiedemann, E. Breukink, C. van Kraaij, O.P. Kuipers, G. Bierbaum, B. de Kruijff, and H.G. Sahl Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity J Biol Chem 276 2001 1772 1779
61. P. Cudic, D.C. Behenna, J.K. Kranz, R.G. Kruger, A.J. Wand, Y.I. Veklich, J.W. Weisel, and D.G. McCafferty Functional analysis of the lipoglycodepsipeptide antibiotic ramoplanin Chem Biol 9 2002 897 906
62. Y.I. Lin, Z. Li, G.D. Francisco, L.A. McDonald, R.A. Davis, G. Singh, Y. Yang, and T.S. Mansour Muraymycins, novel peptidoglycan biosynthesis inhibitors: semisynthesis and SAR of their derivatives Bioorg Med Chem Lett 12 2002 2341 2344
63. A. Ruzin, G. Singh, A. Severin, Y. Yang, R.G. Dushin, A.G. Sutherland, A. Minnick, M. Greenstein, M.K. May, and D.M. Shlaes Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant Gram-positive bacteria Antimicrob Agents Chemother 48 2004 728 738
64. A. Zervosen, W.P. Lu, Z. Chen, R.E. White, T.P. Demuth Jr., and J.M. Frere Interactions between penicillin-binding proteins (PBPs) and two novel classes of PBP inhibitors, arylalkylidene rhodanines and arylalkylidene iminothiazolidin-4-ones Antimicrob Agents Chemother 48 2004 961 969
65. R. Bals, and J.M. Wilson Cathelicidins-a family of multifunctional antimicrobial peptides Cell Mol Life Sci 60 2003 711 720
66. A.M. Cole Minidefensins and other antimicrobial peptides: candidate anti-HIV microbicides Expert Opin Ther Targets 7 2003 329 341
67. K. O'Riordan, and J.C. Lee Staphylococcus aureus capsular polysaccharides Clin Microbiol Rev 17 2004 218 234 This review gives a excellent insight into the biosynthesis and role in virulence of the predominant serotype 215 and 218 capsular polysaccharides of S. aureus. These polysaccharides are the basis of an effective S. aureus vaccine.
68. T.T. Luong, and C.Y. Lee Overproduction of type 8 capsular polysaccharide augments Staphylococcus aureus virulence Infect Immun 70 2002 3389 3395
69. A.I. Fattom, G. Horwith, S. Fuller, M. Propst, and R. Naso Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials Vaccine 22 2004 880 887 The vaccine is based on the two most prevalent capsular polysaccharides, types 885 and 888, of S. aureus. It is interesting that this conjugate vaccine promotes a Th882 response.
70. A.E. Hall, P.J. Domanski, P.R. Patel, J.H. Vernachio, P.J. Syribeys, E.L. Gorovits, M.A. Johnson, J.M. Ross, J.T. Hutchins, and J.M. Patti Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A Infect Immun 71 2003 6864 6870 It has long been known that the fibrinogen binding protein ClfA plays a role in S. aureus virulence and cell invasion. The protective role of monoclonal antibody in a murine sepsis model corroborates the importance of this virulence factor.
71. N. Palmqvist, J.M. Patti, A. Tarkowski, and E. Josefsson Expression of staphylococcal clumping factor A impedes macrophage phagocytosis Microbes Infect 6 2004 188 195
72. M. Kuroda, T. Ohta, I. Uchiyama, T. Baba, H. Yuzawa, I. Kobayashi, L. Cui, A. Oguchi, K. Aoki, and Y. Nagai Whole genome sequencing of methicillin-resistant Staphylococcus aureus Lancet 357 2001 1225 1240 This is the publication of the first Staphylococcus genomes. This paper marks a milestone in staphylococcal genome and virulence analysis.
73. Y.Q. Zhang, S.X. Ren, H.L. Li, Y.X. Wang, G. Fu, J. Yang, Z.Q. Qin, Y.G. Miao, W.Y. Wang, and R.S. Chen Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228) Mol Microbiol 49 2003 1577 1593
74. J.E. Bandow, H. Brötz, L.I. Leichert, H. Labischinski, and M. Hecker Proteomic approach to understanding antibiotic action Antimicrob Agents Chemother 47 2003 948 955 With proteomic technology it is possible to elucidate the complex cellular responses in bacteria and to obtain information as to the site of action of an unknown antibiotic.
75. R.A. Forsyth, R.J. Haselbeck, K.L. Ohlsen, R.T. Yamamoto, H. Xu, J.D. Trawick, D. Wall, L. Wang, V. Brown-Driver, and J.M. Froelich A genome-wide strategy for the identification of essential genes in Staphylococcus aureus Mol Microbiol 43 2002 1387 1400